Abstract
The aim of our study was to assess the prevalence of lower urinary tract symptoms (LUTS) in Austrian males and to correlate the findings with sociodemographic variables. In a population-based cross-sectional study in Austria in the year 1995, data on voiding symptoms were collected from a representative sample of men by using the International Prostate Symptom Score (IPSS). Only 28.6% of the males aged 15 to 89 years (total n = 939) reported no LUTS at all (IPSS = 0). In the group of males who report symptoms, a positive correlation of the IPSS with age is found. Furthermore IPSS correlates with weekly alcohol and nicotine consumption, but not with the respondent's body-mass index (BMI), educational status and monthly household income. The bothersomeness of LUTS increases with age, leaving more than 12% of the males aged 40 to 89 dissatisfied with urinary symptoms. Extrapolated to population numbers, more than 87,000 males in Austria (aged 15 to 89 years) would feel ‘terribly’ if they were to spend the rest of their lives with urinary symptoms as they were at the time of the survey. Due to an estimated future increase of the proportion of older people in Austria, the number of males with LUTS will rise significantly, thereby placing increased burden on medical resources in the future.
Similar content being viewed by others
References
Berry SJ, Coffey DS, Walsh PC. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474–479.
Schwarz B, Vutuc C, Kunze M. Gesundheitsoekonomische Aspekte der benignen Prostatahyperplasie in Oesterreich. Wien Med Wochenschr 1993; 22: 571–573.
Garraway WM, Collins GN, Lee RJ. High prevalence of prostatic hypertrophy in the community. Lancet 1991; 338: 469–471.
Badia X, Garcia-Losa M, Dal-Ré R. Ten-language translation and harmonization of the international prostate symptom score: Developing a methodology for multinational clinical trials. Eur Urol 1997; 31: 129–140.
Madersbacher S, Haidinger G, Temml C, Schmidbauer CP, for the Prostate study group of the austrian society of urology. Prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2096 men. Eur Urol 1998; 34: 136–141.
Barry MJ, Fowler FJ, O'Leary MP, et al. The American urological association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549–1557.
Oesterreichisches Statistisches Zentralamt (eds). Gesundheitsstatistisches Jahrbuch 1995/96. Vienna, Oesterreichische Staatsdruckerei 1998.
Guess HA. Population-based studies of benign prostatic hyperplasia. In: Kirby R, McConnell J, Fitzpatrick J, Roehrborn C, Boyle P (eds), Textbook of benign prostatic hyperplasia. Oxford, UK: Isis Medical Media Ltd, 1996: 117–124.
Boyle P, Barry MJ, Farah R, et al. Epidemiology and natural history of benign prostatic hyperplasia. In: Denis L, Griffiths K, Khoury S, et al. (eds), 4th International Consultation on BPH. Paris, 2–5 July 1997. Proceedings. Plymouth, United Kingdom: Plymbridge Distributors Ltd, 1998: 25–59.
Tsukamoto T, Kumamoto Y, Masumori N, et al. Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. J Urol 1995; 154: 391–395.
Lee E, Park M-S, Shin C, et al. A high-risk group for prostatism: A population-based epidemiological study in Korea. Br J Urol 1997; 79: 736–741.
Norman RW, Nickel JC, Fish D, et al. 'Prostate-related symptoms’ in Canadian men 50 years of age or older: Prevalence and relationships among symptoms. Br J Urol 1994; 74: 542–550.
Hunter DJW, Berra-Unamuno A, Martin-Gordo A. Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old or older. J Urol 1996; 155: 1965–1970.
Hunter DJ, McKee CM, Black NA, et al. Urinary symptoms: Prevalence and severity in British men aged 55 and over. J Epidemiol Community Health 1994; 48: 569–575.
Chicharro-Molero JA, Burgos-Rodriguez R, Sanchez-Cruz JJ, et al. Prevalence of benign prostatic hyperplasia in Spanish men 40 years old or older. J Urol 1998; 159: 878–882.
Sagnier P-P, MacFarlane G, Teillac P, Botto H, Richard F, Boyle P. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community. J Urol 1995; 153: 669–673.
Girman CJ, Panser LA, Chute CG, et al. Natural history of prostatism: urinary flow rates in a population-based study. J Urol 1993; 150: 887–892.
Guess HA, Chute CG, Garraway WM, et al. Similar levels of urological symptoms have similar impact in Scottish and American men — although Scots report less symptoms. J Urol 1993; 150: 1701–1705.
Sagnier P-P, Girman CJ, Garraway M, et al. International comparison of the community prevalence of symptoms of prostatism in four countries. Eur Urol 1996; 29: 15–20.
Bosch JLHR, Hop WCJ, Kirkels WJ, Schröder FH. The International Prostate Symptom Score in a community based sample of men between 55 and 74 years of age: Prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Brit J Urol 1995; 75: 622–630.
Roberts RO, Jacobsen SJ, Rhodes T, et al. Cigarette smoking and prostatism: A biphasic association? Urology 1994; 43: 797–801.
Roberts RO, Tsukamoto T, Kumamoto Y, et al. Association between cigarette smoking and prostatism in a Japanese community. Prostate 1997; 30: 154–159.
Bundesministerium für Gesundheit und Konsumentenschutz in Zusammenarbeit mit dem Oesterreichischen Statistischen Zentralamt: Bericht ueber das Gesundheitswesen in Oesterreich im Jahre 1993. Vienna, Oesterreichische Staatsdruckerei 1995.
Fowler FJ, Wennberg JE, Timothy RP, Barry MJ, Mulley AG, Hanley D. Symptom status and quality of life following prostatectomy. JAMA 1988; 259: 3018–3022.
Fowler FJ. Patient reports of symptoms and quality of life following prostate surgery. Eur Urol 1991; 20(Suppl 2): 44–49.
Grayhack JT. Benign Prostatic Hyperplasia: The scope of the problem. Cancer 1992; 70: 275–279.
Hanika A. Bevoelkerungsvorausschaetzung 1991 bis 2030 des Oesterreichischen Statistischen Zentralamtes für Oesterreich und die Bundeslaender sowie Modellrechnung bis 2050. Statistische Nachrichten 1991; 46: 800–811.
Haidinger G, Waldhoer T, Tuomilehto J, Vutuc C. Assessment of costs related to hospitalization of stroke patients in Austria for 1992 and prospective costs for the year 2010. Cerebrovasc Dis 1997; 7: 163–167.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haidinger, G., Madersbacher, S., Waldhoer, T. et al. The prevalence of lower urinary tract symptoms in Austrian males andassociations with sociodemographic variables. Eur J Epidemiol 15, 717–722 (1999). https://doi.org/10.1023/A:1007605826026
Issue Date:
DOI: https://doi.org/10.1023/A:1007605826026